Related Experiment Video

Updated: Dec 4, 2025

Microdialysis of Excitatory Amino Acids During EEG Recordings in Freely Moving Rats
08:47

Microdialysis of Excitatory Amino Acids During EEG Recordings in Freely Moving Rats

Published on: November 8, 2018

11.8K

Decreased Cerebrospinal Fluid Orexin-A (Hypocretin-1) Concentrations in Patients after Generalized Convulsive Status

Mojdeh Samzadeh1, Ewa Papuć1, Marzena Furtak-Niczyporuk2

  • 1Department of Neurology, Medical University of Lublin, 20-954 Lublin, Poland.

Journal of Clinical Medicine
|October 22, 2020
PubMed

Insights

Cerebrospinal fluid orexin-A levels are significantly lower in patients after generalized convulsive status epilepticus (GCSE). Lower orexin-A concentrations correlate with poorer outcomes, suggesting a role for the orexin system in GCSE pathogenesis.

Area of Science:

  • Neuroscience
  • Endocrinology
  • Epileptology

Background:

  • The orexin/hypocretin system's role in status epilepticus (SE) remains unexplored.
  • Orexin-A, a key neuropeptide, is crucial for regulating arousal and homeostasis.

Purpose of the Study:

  • To investigate cerebrospinal fluid (CSF) orexin-A levels in patients following generalized convulsive status epilepticus (GCSE).
  • To assess the correlation between CSF orexin-A levels and clinical outcomes post-GCSE.

Main Methods:

  • Orexin-A levels were measured using radioimmunoassay in CSF samples from 20 GCSE patients, 24 epilepsy remission (ER) patients, and 25 controls (CTR).
  • Lumbar punctures were performed 3-10 days post-seizure cessation for GCSE patients.
  • Clinical outcomes were assessed using the modified Rankin Scale (mRS) at 1-month follow-up.

Main Results:

  • A significant difference in median CSF orexin-A concentrations was observed across groups (p < 0.001).
  • GCSE patients exhibited significantly lower orexin-A levels compared to ER and CTR groups (p < 0.001).
  • CSF orexin-A levels showed an inverse correlation with 1-month mRS scores in GCSE patients (r = -0.55, p = 0.1).

Conclusions:

  • Reduced CSF orexin-A levels post-GCSE may indicate increased peptide turnover or neuronal damage.
  • The orexin system is implicated in the pathogenesis of status epilepticus.
  • CSF orexin-A may serve as a potential biomarker for GCSE severity and outcome.
Keywords:
biomarkercerebrospinal fluidgeneralized convulsive status epilepticushypocretin 1orexin-A

More Related Videos

Manipulation of Epileptiform Electrocorticograms ECoGs and Sleep in Rats and Mice by Acupuncture09:06

Manipulation of Epileptiform Electrocorticograms ECoGs and Sleep in Rats and Mice by Acupuncture

Published on: December 22, 2016

9.9K
Continuous Video Electroencephalogram during Hypoxia-Ischemia in Neonatal Mice09:29

Continuous Video Electroencephalogram during Hypoxia-Ischemia in Neonatal Mice

Published on: June 11, 2020

3.6K

Related Concept Videos

Sleep-Wake Cycles01:24

Sleep-Wake Cycles

Sleep is an essential physiological process vital to maintaining overall well-being. The reticular activating system (RAS), a network of neurons in the brainstem, regulates wakefulness and sleep. While it may seem passive, sleep consists of distinct cycles, each with its unique characteristics and functions. Two key sleep phases are non-rapid eye movement (NREM) and  rapid eye movement (REM).
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge:
2.5K
Narcolepsy01:07

Narcolepsy

Narcolepsy is a chronic sleep disorder characterized by pervasive, uncontrolled sleepiness and other sleep disturbances. One of its hallmark symptoms is an abrupt transition to REM sleep upon falling asleep, which causes symptoms typically associated with this phase to occur unexpectedly during wakefulness. These include the following symptoms, which typically last from a minute or two to half an hour.
342
Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
479
Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
982
Sedatives and Hypnotics Drugs: Miscellaneous Agents01:17

Sedatives and Hypnotics Drugs: Miscellaneous Agents

Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
361
Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
1.1K